{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T20:11:46Z","timestamp":1770754306088,"version":"3.50.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Radiol"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1007\/s00247-019-04489-z","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T13:04:50Z","timestamp":1571231090000},"page":"1534-1544","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Functional and anatomical imaging in pediatric oncology: which is best for which tumors"],"prefix":"10.1007","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2092-2219","authenticated-orcid":false,"given":"Stephan D.","family":"Voss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,10,16]]},"reference":[{"key":"4489_CR1","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1148\/radiol.11101352","volume":"261","author":"HJ Brisse","year":"2011","unstructured":"Brisse HJ, McCarville MB, Granata C et al (2011) Guidelines for imaging and staging of neuroblastic tumors: consensus report from the international neuroblastoma risk group project. Radiology 261:243\u2013257","journal-title":"Radiology"},{"key":"4489_CR2","doi-asserted-by":"crossref","unstructured":"Dumba M, Jawad N, McHugh K (2015) Neuroblastoma and nephroblastoma: a radiological review. Cancer Imaging 15(5)","DOI":"10.1186\/s40644-015-0040-6"},{"key":"4489_CR3","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.crad.2014.04.006","volume":"69","author":"SA Kembhavi","year":"2014","unstructured":"Kembhavi SA, Rangarajan V, Shah S et al (2014) Prospective observational study on diagnostic accuracy of whole-body MRI in solid small round cell tumours. Clin Radiol 69:900\u2013908","journal-title":"Clin Radiol"},{"key":"4489_CR4","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1053\/j.semnuclmed.2016.02.002","volume":"46","author":"MT Parisi","year":"2016","unstructured":"Parisi MT, Eslamy H, Park JR et al (2016) (1)(3)(1)I-metaiodobenzylguanidine theranostics in neuroblastoma: historical perspectives; practical applications. Semin Nucl Med 46:184\u2013202","journal-title":"Semin Nucl Med"},{"key":"4489_CR5","doi-asserted-by":"publisher","first-page":"2580","DOI":"10.1200\/JCO.2016.72.0177","volume":"35","author":"JR Park","year":"2017","unstructured":"Park JR, Bagatell R, Cohn SL et al (2017) Revisions to the international neuroblastoma response criteria: a consensus statement from the National Cancer Institute clinical trials planning meeting. J Clin Oncol 35:2580\u20132587","journal-title":"J Clin Oncol"},{"key":"4489_CR6","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1053\/j.semnuclmed.2016.10.007","volume":"47","author":"T Pfluger","year":"2017","unstructured":"Pfluger T, Piccardo A (2017) Neuroblastoma: MIBG imaging and new tracers. Semin Nucl Med 47:143\u2013157","journal-title":"Semin Nucl Med"},{"key":"4489_CR7","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1148\/rg.2016150099","volume":"36","author":"SE Sharp","year":"2016","unstructured":"Sharp SE, Trout AT, Weiss BD et al (2016) MIBG in neuroblastoma diagnostic imaging and therapy. Radiographics 36:258\u2013278","journal-title":"Radiographics"},{"key":"4489_CR8","doi-asserted-by":"crossref","unstructured":"DuBois SG, Mody R, Naranjo A et al (2017) MIBG avidity correlates with clinical features, tumor biology, and outcomes in neuroblastoma: a report from the Children's oncology group. Pediatr Blood Cancer 64","DOI":"10.1002\/pbc.26545"},{"key":"4489_CR9","doi-asserted-by":"crossref","unstructured":"Gauguet JM, Pace-Emerson T, Grant FD et al (2017) Evaluation of the utility of (99m) Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. Pediatr Blood Cancer 64","DOI":"10.1002\/pbc.26601"},{"key":"4489_CR10","doi-asserted-by":"crossref","unstructured":"Bleeker G, Tytgat GA, Adam JA et al (2015) 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma. Cochrane Database Syst Rev (2015):CD009263","DOI":"10.1002\/14651858.CD009263.pub2"},{"key":"4489_CR11","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1038\/sj.bjc.6605621","volume":"102","author":"KK Matthay","year":"2010","unstructured":"Matthay KK, Shulkin B, Ladenstein R et al (2010) Criteria for evaluation of disease extent by (123)I-metaiodobenzylguanidine scans in neuroblastoma: a report for the international neuroblastoma risk group (INRG) task force. Br J Cancer 102:1319\u20131326","journal-title":"Br J Cancer"},{"key":"4489_CR12","doi-asserted-by":"publisher","first-page":"502","DOI":"10.2967\/jnumed.117.195883","volume":"59","author":"GA Yanik","year":"2018","unstructured":"Yanik GA, Parisi MT, Naranjo A et al (2018) Validation of postinduction curie scores in high-risk neuroblastoma: a Children's oncology group and SIOPEN group report on SIOPEN\/HR-NBL1. J Nucl Med 59:502\u2013508","journal-title":"J Nucl Med"},{"key":"4489_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1007\/s00259-017-3829-7","volume":"45","author":"R Ladenstein","year":"2018","unstructured":"Ladenstein R, Lambert B, Potschger U et al (2018) Validation of the mIBG skeletal SIOPEN scoring method in two independent high-risk neuroblastoma populations: the SIOPEN\/HR-NBL1 and COG-A3973 trials. Eur J Nucl Med Mol Imaging 45:292\u2013305","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4489_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.2344\/0003-3006-64.2.57","volume":"64","author":"S Ganzberg","year":"2017","unstructured":"Ganzberg S (2017) The FDA warning on anesthesia drugs. Anesth Prog 64:57\u201358","journal-title":"Anesth Prog"},{"key":"4489_CR15","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1148\/radiol.2016160356","volume":"282","author":"TF Flood","year":"2017","unstructured":"Flood TF, Stence NV, Maloney JA et al (2017) Pediatric brain: repeated exposure to linear gadolinium-based contrast material is associated with increased signal intensity at unenhanced T1-weighted MR imaging. Radiology 282:222\u2013228","journal-title":"Radiology"},{"key":"4489_CR16","first-page":"205521731770445","volume":"3","author":"HK Goischke","year":"2017","unstructured":"Goischke HK (2017) Safety assessment of gadolinium-based contrast agents (GBCAs) requires consideration of long-term adverse effects in all human tissues. Mult Scler J Exp Transl Clin 3:2055217317704450","journal-title":"Mult Scler J Exp Transl Clin"},{"key":"4489_CR17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00247-017-4023-6","volume":"48","author":"MJ Callahan","year":"2018","unstructured":"Callahan MJ, MacDougall RD, Bixby SD et al (2018) Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. Pediatr Radiol 48:21\u201330","journal-title":"Pediatr Radiol"},{"key":"4489_CR18","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/s00247-018-4078-z","volume":"48","author":"AJ Towbin","year":"2018","unstructured":"Towbin AJ, Meyers RL, Woodley H et al (2018) 2017 PRETEXT: radiologic staging system for primary hepatic malignancies of childhood revised for the Paediatric hepatic international tumour trial (PHITT). Pediatr Radiol 48:536\u2013554","journal-title":"Pediatr Radiol"},{"key":"4489_CR19","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/pbc.20524","volume":"47","author":"RJ Mody","year":"2006","unstructured":"Mody RJ, Pohlen JA, Malde S et al (2006) FDG PET for the study of primary hepatic malignancies in children. Pediatr Blood Cancer 47:51\u201355","journal-title":"Pediatr Blood Cancer"},{"key":"4489_CR20","doi-asserted-by":"publisher","first-page":"709037","DOI":"10.1155\/2013\/709037","volume":"2013","author":"A Cistaro","year":"2013","unstructured":"Cistaro A, Treglia G, Pagano M et al (2013) A comparison between (1)(8)F-FDG PET\/CT imaging and biological and radiological findings in restaging of hepatoblastoma patients. Biomed Res Int 2013:709037","journal-title":"Biomed Res Int"},{"key":"4489_CR21","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/j.ejca.2010.09.039","volume":"47","author":"J Begent","year":"2011","unstructured":"Begent J, Sebire NJ, Levitt G et al (2011) Pilot study of F(18)-fluorodeoxyglucose positron emission tomography\/computerised tomography in Wilms' tumour: correlation with conventional imaging, pathology and immunohistochemistry. Eur J Cancer 47:389\u2013396","journal-title":"Eur J Cancer"},{"key":"4489_CR22","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1007\/s00259-010-1396-2","volume":"37","author":"AK Moinul Hossain","year":"2010","unstructured":"Moinul Hossain AK, Shulkin BL, Gelfand MJ et al (2010) FDG positron emission tomography\/computed tomography studies of Wilms' tumor. Eur J Nucl Med Mol Imaging 37:1300\u20131308","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4489_CR23","doi-asserted-by":"publisher","first-page":"633","DOI":"10.3109\/08880018.2013.832446","volume":"30","author":"M Provenzi","year":"2013","unstructured":"Provenzi M, Saettini F, Conter V et al (2013) Is there a role for FDG-PET for the assessment of treatment efficacy in Wilms' tumor? A case report and literature review. Pediatr Hematol Oncol 30:633\u2013639","journal-title":"Pediatr Hematol Oncol"},{"key":"4489_CR24","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1053\/j.semnuclmed.2016.12.004","volume":"47","author":"DJ Harrison","year":"2017","unstructured":"Harrison DJ, Parisi MT, Shulkin BL (2017) The role of (18)F-FDG-PET\/CT in pediatric sarcoma. Semin Nucl Med 47:229\u2013241","journal-title":"Semin Nucl Med"},{"key":"4489_CR25","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/pbc.26014","volume":"63","author":"C Hurley","year":"2016","unstructured":"Hurley C, McCarville MB, Shulkin BL et al (2016) Comparison of (18) F-FDG-PET-CT and bone scintigraphy for evaluation of osseous metastases in newly diagnosed and recurrent osteosarcoma. Pediatr Blood Cancer 63:1381\u20131386","journal-title":"Pediatr Blood Cancer"},{"key":"4489_CR26","doi-asserted-by":"crossref","unstructured":"Croteau NJ, Heaton TE (2019) Pulmonary metastasectomy in pediatric solid tumors. Children 6","DOI":"10.3390\/children6010006"},{"key":"4489_CR27","doi-asserted-by":"publisher","first-page":"W900","DOI":"10.2214\/AJR.12.10205","volume":"201","author":"MB McCarville","year":"2013","unstructured":"McCarville MB, Billups C, Wu J et al (2013) The role of PET\/CT in assessing pulmonary nodules in children with solid malignancies. AJR Am J Roentgenol 201:W900\u2013W905","journal-title":"AJR Am J Roentgenol"},{"key":"4489_CR28","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1007\/s00259-014-2746-2","volume":"41","author":"BH Byun","year":"2014","unstructured":"Byun BH, Kong CB, Lim I et al (2014) Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential (1)(8)F-FDG PET\/CT and MRI. Eur J Nucl Med Mol Imaging 41:1553\u20131562","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4489_CR29","doi-asserted-by":"publisher","first-page":"3519","DOI":"10.1002\/cncr.24421","volume":"115","author":"DS Hawkins","year":"2009","unstructured":"Hawkins DS, Conrad EU 3rd, Butrynski JE et al (2009) [F-18]-fluorodeoxy-D-glucose-positron emission tomography response is associated with outcome for extremity osteosarcoma in children and young adults. Cancer 115:3519\u20133525","journal-title":"Cancer"},{"key":"4489_CR30","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1007\/s00247-017-3963-1","volume":"47","author":"SE Sharp","year":"2017","unstructured":"Sharp SE, Shulkin BL, Gelfand MJ et al (2017) FDG PET\/CT appearance of local osteosarcoma recurrences in pediatric patients. Pediatr Radiol 47:1800\u20131808","journal-title":"Pediatr Radiol"},{"key":"4489_CR31","doi-asserted-by":"publisher","first-page":"8828","DOI":"10.1200\/JCO.2005.01.7079","volume":"23","author":"DS Hawkins","year":"2005","unstructured":"Hawkins DS, Schuetze SM, Butrynski JE et al (2005) [18F] fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors. J Clin Oncol 23:8828\u20138834","journal-title":"J Clin Oncol"},{"key":"4489_CR32","doi-asserted-by":"publisher","first-page":"274","DOI":"10.2967\/jnumed.114.146290","volume":"56","author":"L Uslu","year":"2015","unstructured":"Uslu L, Donig J, Link M et al (2015) Value of 18F-FDG PET and PET\/CT for evaluation of pediatric malignancies. J Nucl Med 56:274\u2013286","journal-title":"J Nucl Med"},{"key":"4489_CR33","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1002\/pbc.24430","volume":"60","author":"SM Federico","year":"2013","unstructured":"Federico SM, Spunt SL, Krasin MJ et al (2013) Comparison of PET-CT and conventional imaging in staging pediatric rhabdomyosarcoma. Pediatr Blood Cancer 60:1128\u20131134","journal-title":"Pediatr Blood Cancer"},{"key":"4489_CR34","doi-asserted-by":"crossref","unstructured":"Borinstein SC, Steppan D, Hayashi M et al (2018) Consensus and controversies regarding the treatment of rhabdomyosarcoma. Pediatr Blood Cancer 65","DOI":"10.1002\/pbc.26809"},{"key":"4489_CR35","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1016\/j.jpedsurg.2013.04.013","volume":"48","author":"KM Alcorn","year":"2013","unstructured":"Alcorn KM, Deans KJ, Congeni A et al (2013) Sentinel lymph node biopsy in pediatric soft tissue sarcoma patients: utility and concordance with imaging. J Pediatr Surg 48:1903\u20131906","journal-title":"J Pediatr Surg"},{"key":"4489_CR36","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/cncr.30282","volume":"123","author":"LM Wagner","year":"2017","unstructured":"Wagner LM, Kremer N, Gelfand MJ et al (2017) Detection of lymph node metastases in pediatric and adolescent\/young adult sarcoma: sentinel lymph node biopsy versus fludeoxyglucose positron emission tomography imaging \u2014 a prospective trial. Cancer 123:155\u2013160","journal-title":"Cancer"},{"key":"4489_CR37","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.ijrobp.2014.08.005","volume":"90","author":"DL Casey","year":"2014","unstructured":"Casey DL, Wexler LH, Fox JJ et al (2014) Predicting outcome in patients with rhabdomyosarcoma: role of [(18)f]fluorodeoxyglucose positron emission tomography. Int J Radiat Oncol Biol Phys 90:1136\u20131142","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4489_CR38","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1007\/s00259-012-2278-6","volume":"40","author":"WP Mueller","year":"2013","unstructured":"Mueller WP, Melzer HI, Schmid I et al (2013) The diagnostic value of 18F-FDG PET and MRI in paediatric histiocytosis. Eur J Nucl Med Mol Imaging 40:356\u2013363","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"4489_CR39","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s41598-018-36501-1","volume":"9","author":"JR Kim","year":"2019","unstructured":"Kim JR, Yoon HM, Jung AY et al (2019) Comparison of whole-body MRI, bone scan, and radiographic skeletal survey for lesion detection and risk stratification of Langerhans cell histiocytosis. Sci Rep 9:317","journal-title":"Sci Rep"},{"key":"4489_CR40","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1007\/s11547-015-0600-7","volume":"121","author":"RA Nievelstein","year":"2016","unstructured":"Nievelstein RA, Littooij AS (2016) Whole-body MRI in paediatric oncology. Radiol Med 121:442\u2013453","journal-title":"Radiol Med"},{"key":"4489_CR41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/pbc.21782","volume":"52","author":"M Phillips","year":"2009","unstructured":"Phillips M, Allen C, Gerson P et al (2009) Comparison of FDG-PET scans to conventional radiography and bone scans in management of Langerhans cell histiocytosis. Pediatr Blood Cancer 52:97\u2013101","journal-title":"Pediatr Blood Cancer"},{"key":"4489_CR42","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s11060-012-0840-5","volume":"108","author":"LL Tsai","year":"2012","unstructured":"Tsai LL, Drubach L, Fahey F et al (2012) [18F]-fluorodeoxyglucose positron emission tomography in children with neurofibromatosis type 1 and plexiform neurofibromas: correlation with malignant transformation. J Neuro-Oncol 108:469\u2013475","journal-title":"J Neuro-Oncol"},{"key":"4489_CR43","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/cncr.24755","volume":"116","author":"MR Benz","year":"2010","unstructured":"Benz MR, Czernin J, Dry SM et al (2010) Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 116:451\u2013458","journal-title":"Cancer"},{"key":"4489_CR44","doi-asserted-by":"publisher","first-page":"e46","DOI":"10.1158\/1078-0432.CCR-17-0589","volume":"23","author":"DGR Evans","year":"2017","unstructured":"Evans DGR, Salvador H, Chang VY et al (2017) Cancer and central nervous system tumor surveillance in pediatric neurofibromatosis 1. Clin Cancer Res 23:e46\u2013e53","journal-title":"Clin Cancer Res"},{"key":"4489_CR45","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1200\/JCO.2011.37.4355","volume":"30","author":"S Malempati","year":"2012","unstructured":"Malempati S, Weigel B, Ingle AM et al (2012) Phase I\/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's oncology group. J Clin Oncol 30:256\u2013262","journal-title":"J Clin Oncol"},{"key":"4489_CR46","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.1200\/JCO.2017.73.4830","volume":"35","author":"YP Mosse","year":"2017","unstructured":"Mosse YP, Voss SD, Lim MS et al (2017) Targeting ALK with crizotinib in pediatric anaplastic large cell lymphoma and inflammatory myofibroblastic tumor: a Children's oncology group study. J Clin Oncol 35:3215\u20133221","journal-title":"J Clin Oncol"},{"key":"4489_CR47","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1097\/MPH.0000000000000411","volume":"38","author":"G Kong","year":"2016","unstructured":"Kong G, Hofman MS, Murray WK et al (2016) Initial experience with gallium-68 DOTA-octreotate PET\/CT and peptide receptor radionuclide therapy for pediatric patients with refractory metastatic neuroblastoma. J Pediatr Hematol Oncol 38:87\u201396","journal-title":"J Pediatr Hematol Oncol"},{"key":"4489_CR48","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1039\/C3DT52647J","volume":"43","author":"BM Paterson","year":"2014","unstructured":"Paterson BM, Roselt P, Denoyer D et al (2014) PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate. Dalton Trans 43:1386\u20131396","journal-title":"Dalton Trans"},{"key":"4489_CR49","doi-asserted-by":"publisher","first-page":"147","DOI":"10.2967\/jnumed.117.193169","volume":"59","author":"N Pandit-Taskar","year":"2018","unstructured":"Pandit-Taskar N, Zanzonico P, Staton KD et al (2018) Biodistribution and dosimetry of (18)F-meta-fluorobenzylguanidine: a first-in-human PET\/CT imaging study of patients with neuroendocrine malignancies. J Nucl Med 59:147\u2013153","journal-title":"J Nucl Med"}],"container-title":["Pediatric Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04489-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00247-019-04489-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00247-019-04489-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T23:36:07Z","timestamp":1602718567000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00247-019-04489-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10]]},"references-count":49,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["4489"],"URL":"https:\/\/doi.org\/10.1007\/s00247-019-04489-z","relation":{},"ISSN":["0301-0449","1432-1998"],"issn-type":[{"value":"0301-0449","type":"print"},{"value":"1432-1998","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"9 April 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 October 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}